Navigation Links
High levels of circulating DNA may signal faster progression of lung cancer
Date:1/31/2011

High levels of circulating DNA may indicate faster progression of lung cancer and lower overall survival, according to a study published in the February edition of the Journal of Thoracic Oncology, the official publication of the International Association for the Study of Lung Cancer (IASLC).

"Thirty-three years ago it was demonstrated that cancer patients presented more free DNA in the blood than healthy people, and further investigations confirmed that much of the circulating DNA in the patients with cancer derives from the tumor," said Rafael Sirera, an associate professor of immunology at the Polytechnic University of Valencia in Valencia, Spain. "Although circulating DNA in established cancers demonstrated a strong power to discriminate patients with lung cancer from those with benign lung diseases or healthy individuals, several critical voices were raised against its relevance for screening and diagnostics."

The study analyzed blood samples from 446 patients with advanced non-small cell lung cancer, all of whom were enrolled in a multicenter clinical trial of the Spanish Lung Cancer Group between February 2003 and January 2005. Levels of free human telomerase reverse transcriptase (hTERT), as a surrogate of circulating DNA, were determined before the planned start of combination chemotherapy with cisplatin and docetaxel.

Patients with hTERT levels below 49.8 nanograms per milliliter (ng/ml) had a median time to progression (TTP) of 6.3 months, compared with 4.9 months for patients with hTERT of more than 49.8 ng/ml.

In addition, patients with the lower hTERT levels had higher overall survival, at 10.9 months versus 9.3 months for patients with higher hTERT.

A key strength of the study was its larger population size, compared with similar studies that included fewer than 100 patients.

"The standardization of sample source, processing, DNA extraction and titration methods gives a strong reliability to our results," Sirera said. "Another important aspect that should be emphasized is that the DNA concentrations in our study did not seem to be influenced by either pretreatment tumor characteristics or clinical variables."

Because hTERT analysis depends on a simple, noninvasive and affordable procedure that can be performed in sequential samples from the same patient, it could be an important aid in therapy evaluations and follow-up of patients with non-small cell lung cancer, Sirera said.


'/>"/>

Contact: Rene McGaw
renee.mcgaw@ucdenver.edu
303-724-5796
International Association for the Study of Lung Cancer
Source:Eurekalert

Related medicine news :

1. Workers most invested in their jobs have highest stress levels, CAMH study shows
2. Researchers find rising levels of hypertension in older Mexican-Americans
3. U.S. Officials Recommend Reduced Fluoride Levels in Water
4. Neural stem cells maintain high levels of reactive oxygen species, UCLA study finds
5. Healthy Habits in Youth Tied to Better Adult Cholesterol Levels
6. Injectable, Oral Birth Control Dont Threaten Glucose, Insulin Levels: Study
7. Vegetarian Diet Cuts Kidney Patients Levels of Toxic Phosphorus
8. Naturally High Hemoglobin Levels May Not Threaten Kidney Patients
9. Vitamin D and parathyroid hormone levels may not affect cardiovascular mortality
10. Obesity Rising Across All Income Levels: CDC
11. Scientists Raise Fat-Burning Levels in Mice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... 24, 2017 , ... i2i Population Health, a national leader in population health ... , “Cary’s broad financial background is an excellent fit for i2i,” says Justin Neece, ... operations skills we need to take the company to the next level of growth.” ...
(Date:1/24/2017)... ... 24, 2017 , ... The Cruise Web Inc. was recognized today ... 4th Annual MSC True Partnerships’ Awards. , The 2016 MSC True Partnerships ... year based on overall business growth in revenue and guests and continuous partnership support ...
(Date:1/24/2017)... , ... January 24, 2017 , ... ... to the semi-final round of the 2017 Cupid's Cup Entrepreneurship Competition. Chaired by ... 12th year in 2017. The entrepreneurs will showcase their businesses on February 6, ...
(Date:1/24/2017)... ... January 24, 2017 , ... West’s Health ... annual Solutions Series of webinars will start January 31 with a session about ... of current health and benefits topics, including employee engagement, pricing transparency, population health ...
(Date:1/24/2017)... ... January 24, 2017 , ... His message has been heard by ... organization End Distracted Driving , Joel Feldman, has reached his biggest national audience ... in one of the top newspapers in circulation in the country, and he hopes ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... GREENVILLE, S.C. , Jan. 24, 2017 ... plans to release its fiscal 2017 first quarter results ... regular trading. The company will conduct a ... 3, to review the company,s financial and operating results for ... of the conference call will be available online at ...
(Date:1/24/2017)... Mich. , Jan. 24, 2017  Diplomat Pharmacy, ... the state of specialty pharmaceuticals, including a recap of ... overview of the pipeline for 2017. The ... Last year, the FDA Center for Drug Evaluation and ... was a reduction in novel new drugs compared to ...
(Date:1/24/2017)... Jan. 24, 2017  The Orthopaedic Implant Company ... high-value orthopaedic implants, announced the launch of its ... The OIC Tibial Nail System is designed ... proximal and distal screw holes accommodate varying fracture ... dynamization.  The nail is available in diameters of ...
Breaking Medicine Technology: